Home > List All Publishers > BioSeeker Group AB

BioSeeker Group AB

BioSeeker Group is a business and competitive intelligence company for investment, venture and R&D management of biotechnology and pharmaceutical companies. It serves the needs of individuals, companies, and institutional clients with a diverse range of information and analysis services.
BioSeeker Group has a strong client focus providing decision-makers, investors, and management people with candid, credible research coverage on biotechnology and pharmaceutical companies. The firm is committed to creating value for clients by providing wisdom and high quality services that meet clients' needs. BioSeeker Group clients and projects are kept confidential.

List of reports from BioSeeker Group AB

Neuroendocrine Tumors Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... Neuroendocrine Tumors Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 54 different targets. These targets are further categorized on in the ... \| more...	$1,499.00
Notch Signaling Pathway in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... drugs in 481 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 101 drugs. Notch Signaling Pathway In Oncology ... \| more...	$1,499.00
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... therapy drugs in 520 developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 177 drugs. Nucleic Acid Therapies In ... \| more...	$2,249.00
Pancreatic Cancer Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... another 95 drugs. Pancreatic Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 198 different targets. These targets are further categorized ... \| more...	$2,249.00
Proteins in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 164 drugs. Proteins In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis ... \| more...	$2,249.00
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... function. Binding of RANKL to RANK leads to the activation of signaling modules such as NF-kappa B, mitogen activated protein kinases (MAPK's), protein kinase C (PKC), Ca2+/Calcineurin/nuclear factor of activated T cells (NFAT) and phosphatidyl ... \| more...	$2,249.00
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... suspended drugs and the accumulated number of ceased drugs over the last years amount to another 172 drugs. Tgf-Beta Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress ... \| more...	$2,249.00
TSH Signaling Pathway in Oncology Drug Pipeline Update 2012 2/21/2012 \| published by: BioSeeker Group AB ... kinases, protein kinase C modules. There are today 135 companies plus partners developing 182 TSH pathway targeting drugs in 551 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number ... \| more...	$2,249.00
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2/21/2012 \| published by: BioSeeker Group AB ... targeting drugs in 273 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 45 drugs. Wnt Signaling Pathway In ... \| more...	$1,499.00
Triple Analysis: Melanoma, Apoptosis and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| more...	$5,175.00
Triple Analysis: Melanoma, Pancreatic Cancer and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| more...	$5,175.00
Triple Analysis: Pancreatic Cancer, Angiogenesis and Antibodies 1/30/2012 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Pancreatic Cancer, Angiogenesis and Cancer Vaccines 1/30/2012 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| more...	$5,175.00
Triple Analysis: Pancreatic Cancer, Apoptosis and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Prostate Cancer, Angiogenesis and Cancer Vaccines 1/30/2012 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| more...	$5,175.00
Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00
Triple Analysis: Angiogenesis, Antibodies and Peptides 1/30/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies 1/30/2012 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Apoptosis, Angiogenesis and Peptides 1/30/2012 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| more...	$5,175.00
Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 1/30/2012 \| published by: BioSeeker Group AB ... drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. Below is a ... \| more...	$5,175.00
Triple Analysis: Breast Cancer, Angiogenesis and Peptides 1/30/2012 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| more...	$5,175.00
Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors 1/30/2012 \| published by: BioSeeker Group AB ... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also ... \| more...	$5,175.00
Triple Analysis: Breast Cancer, Lymphoma and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| more...	$5,175.00
Triple Analysis: Breast Cancer, Pancreatic Cancer and Angiogenesis 1/30/2012 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| more...	$5,175.00

< prev 5 6 7 8 9 10 11 12 13 14 next >